These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 8051400

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of Ly-6A/E and T cell receptor-zeta for IL-2 production. Phosphatidylinositol-anchored Ly-6A/E antagonizes T cell receptor-mediated IL-2 production by a zeta-independent pathway.
    Codias EK, Fleming TJ, Zacharchuk CM, Ashwell JD, Malek TR.
    J Immunol; 1992 Sep 15; 149(6):1825-52. PubMed ID: 1387661
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of IL-2 production by activation of T cells through Ly-6A/E.
    Codias EK, Rutter JE, Fleming TJ, Malek TR.
    J Immunol; 1990 Sep 01; 145(5):1407-14. PubMed ID: 2143518
    [Abstract] [Full Text] [Related]

  • 5. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2).
    Saitoh S, Kosugi A, Noda S, Yamamoto N, Ogata M, Minami Y, Miyake K, Hamaoka T.
    J Immunol; 1995 Dec 15; 155(12):5574-81. PubMed ID: 7499840
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subsets of activated CD4 T lymphocytes refractory for secretion of IL-2 are distinguished by expression of Ly-6A/E in BALB/c mice.
    Codias EK, Malek TR.
    J Immunol; 1993 Dec 01; 151(11):5918-29. PubMed ID: 7902374
    [Abstract] [Full Text] [Related]

  • 8. Activation of T lymphocytes through the Ly-6 pathway is defective in A strain mice.
    Malek TR, Shevach EM, Danis KM.
    J Immunol; 1989 Jul 15; 143(2):439-45. PubMed ID: 2525586
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL, Kung JT.
    J Immunol; 1996 Mar 15; 156(6):2036-44. PubMed ID: 8690890
    [Abstract] [Full Text] [Related]

  • 17. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of an anti-Ly-6 monoclonal antibody which defines and activates cytolytic T lymphocytes.
    Havran WL, Lancki DW, Moldwin RL, Dialynas DP, Fitch FW.
    J Immunol; 1988 Feb 15; 140(4):1034-42. PubMed ID: 3257767
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.